ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

被引:448
|
作者
Orchard, JA
Ibbotson, RE
Davis, Z
Wiestner, A
Rosenwald, A
Thomas, PW
Hamblin, TJ
Staudt, LM
Oscier, DG [1 ]
机构
[1] Royal Bournemouth Hosp, Dept Haematol, Bournemouth BH7 7DW, Dorset, England
[2] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] Poole Hosp, Dorset Res & Dev Support Unit, Poole, Dorset, England
来源
LANCET | 2004年 / 363卷 / 9403期
关键词
D O I
10.1016/S0140-6736(03)15260-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Chronic lymphocytic leukaemia (CLL) is a heterogeneous disease; many patients never need treatment, whereas some have poor outcomes. New treatments, which can induce complete remissions, allow patients with poor outlook to be treated while they are still asymptomatic. Whether or not the IgVH gene is mutated is the best predictor of clinical outcome, but this assay is unsuited to the routine laboratory. The gene coding for ZAP-70, a tyrosine kinase protein normally expressed in T and NK cells, has been shown by gene-expression profiling to be differentially expressed between patients with mutated and unmutated IgVH genes. We assessed whether ZAP-70 could be used as a prognostic marker in CLL. Methods We developed a flow cytometry assay for ZAP-70 protein expression and investigated its concordance with ZAP-70 mRNA expression, IgVH gene mutational status, and clinical outcome in 167 patients with CLL. Findings We showed high concordance between ZAP-70 protein expression and IgVH gene mutations. 108 patients (65%) had mutated IgVH genes and were ZAP-70 negative; 46 (28%) had unmutated IgVH genes and were ZAP-70 positive. Findings were discordant in 13 patients: six (4%) had mutated IgVH genes but were ZAP-70 positive, and seven (4%) had unmutated IgVH genes and were ZAP-70 negative. Expression of mRNA showed 97% concordance with ZAP-70 protein. Median survival was 24.4 years (95% CI 15.1-33.8) in ZAP-70 negative patients and 9.3 years (7.0-11.5) in those who were ZAP-70 positive (hazard ratio 5.5, 2.8-10.8). Interpretation ZAP-70 protein, which can be measured by flow cytometry in the general laboratory, is a reliable prognostic marker in CLL, equivalent to that of IgVH gene mutational status.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 50 条
  • [21] The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia
    Hus, I
    Podhorecka, M
    Bojarska-Junak, A
    Rolinski, J
    Schmitt, M
    Sieklucka, M
    Wasik-Szczepanek, E
    Dmoszynska, A
    ANNALS OF ONCOLOGY, 2006, 17 (04) : 683 - 690
  • [22] Detection of ZAP-70 in patients with chronic lymphocytic leukemia
    Marjanovic, G.
    Stanojevic, I.
    Jankovic-Velickovic, Lj.
    Hubl, W.
    Marjanovic, V.
    JOURNAL OF BUON, 2008, 13 (04): : 543 - 546
  • [23] Detection methods of ZAP-70 in chronic lymphocytic leukemia
    Wang, Yin-Hua
    Fan, Lei
    Xu, Wei
    Li, Jian-Yong
    CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 12 (02) : 69 - 77
  • [24] Discordance of ZAP-70 in patients with chronic lymphocytic leukemia
    Chaar, B. T.
    Schergen, A. K.
    Grosso, L. E.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (01) : 36 - 40
  • [25] What about the physiopathological role of ZAP-70 expression in chronic lymphocytic leukemia?
    Guillaume, Nicolas
    Gouilleux-Gruart, Valerie
    Machu-Prestaux, Nathalie
    Claisse, Jean-Francois
    Capiod, Jean-Claude
    Lefrere, Jean-Jacques
    HEMATOLOGIE, 2006, 12 (04): : 253 - 261
  • [26] Detection methods of ZAP-70 in chronic lymphocytic leukemia
    Yin-Hua Wang
    Lei Fan
    Wei Xu
    Jian-Yong Li
    Clinical and Experimental Medicine, 2012, 12 : 69 - 77
  • [27] Significant change in ZAP-70 expression during the course of chronic lymphocytic leukemia
    Vroblova, Vladimira
    Vrbacky, Filip
    Hrudkova, Monika
    Jankovicova, Karolina
    Schmitzova, Daniela
    Maly, Jaroslav
    Krejsek, Jan
    Smolej, Lukas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (06) : 513 - 517
  • [28] ZAP-70 expression in chronic lymphocytic leukemia is associated with altered signal transduction
    Wolniak, Kristy L.
    Marvin, James
    Goolsby, Charles
    BLOOD, 2007, 110 (11) : 249B - 249B
  • [29] ZAP-70 Expression in B-Chronic Lymphocytic Leukemia in Sudanese Patients
    Abdel-Gader, Enaam Abdel-Rhman
    Eltayeb, Nada Hassan
    Eltahir, Tasniem Ahmed
    Altayeb, Osama Ali
    Fadul, Eman Abbass
    Rahman, Eldirdiri M. Abdel
    Merghani, Tarig H.
    SUDAN JOURNAL OF MEDICAL SCIENCES, 2018, 13 (04): : 230 - 239
  • [30] ZAP-70 expression in chronic lymphocytic leukemia: a new parameter for an old disease
    Bosch, F
    Villamor, N
    HAEMATOLOGICA, 2003, 88 (07) : 724 - 726